Loading...
7 Rare Disease Drugs Reports
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Amgen Inc. , Biomarin Pharmaceuticals , Bayer AG, Bristol-Myers Squibb Company, AstraZeneca (Alexion Pharmaceuticals Inc.)
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company (Celgene Corporation)
Study Period: 2021 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Bavarian Nordic A/S, SIGA Technologies, Chimerix, Inc
Study Period: 2021 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Boehringer Ingelheim International GmbH, Celgene Corporation, arGentis Pharmaceuticals Llc, Kadmon Holdings, Inc., Emerald Health Pharmaceuticals
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: CSL Behring LLC, Takeda Pharmaceutical Company Limited, Grifols SA, Kedrion Biopharma Inc., Octapharma AG
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia Pacific
Major Players: Hoffmann-La Roche Ltd, TG Therapeutics, Opexa Therapeutics, Mitsubishi Tanabe Pharma, Horizon Therapeutics plc (Viela Bio)
Study Period: 2021 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: CSL Ltd, Merz Pharma GmbH & Co. KGaA, Kedrion Biopharma Inc., US WorldMeds LLC (Solstice Neurosciences LLC), Aquestive Therapeutics Inc.
Filter Reports
By Region
By Countries
